FOLLOW US :
  • |
  • |

Equity

Daily Market Tracker
Market Analysis
Other Markets
Corporate Actions
News
Corporate Information

Corporate Results

Back
Bharat Parenterals reports consolidated net loss of Rs 4.73 crore in the March 2025 quarter
(12-May-2025, 18:10 Hours IST)  
Net Loss of Bharat Parenterals reported to Rs 4.73 crore in the quarter ended March 2025 as against net loss of Rs 0.30 crore during the previous quarter ended March 2024. Sales rose 53.32% to Rs 103.98 crore in the quarter ended March 2025 as against Rs 67.82 crore during the previous quarter ended March 2024.

For the full year,net loss reported to Rs 12.63 crore in the year ended March 2025 as against net profit of Rs 14.51 crore during the previous year ended March 2024. Sales rose 30.30% to Rs 340.38 crore in the year ended March 2025 as against Rs 261.22 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales103.9867.82 53 340.38261.22 30
OPM %2.141.47 -0.7910.37 -
PBDT0.222.51 -91 1.3727.74 -95
PBT-8.30-1.36 -510 -33.9518.72 PL
NP-4.73-0.30 -1477 -12.6314.51 PL

Powered by Capital Market - Live News

IMPORTANT LINKS

QUICK LINKS

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)